Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

(marketscreener.com) CHARLOTTESVILLE, Va., May 08, 2024 -- Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in a fireside chat at the 2024 Bank of America...
https://www.marketscreener.com/quote/stock/ACUMEN-PHARMACEUTICALS-IN-124221574/news/Acumen-Pharmaceuticals-to-Participate-in-the-2024-Bank-of-America-Healthcare-Conference-46670865/?utm_medium=RSS&utm_content=20240508